Suzlon soars 20% on Shanghvi deal; adds Rs 1,089 cr to m-cap

Last Updated: Monday, February 16, 2015, 23:38

Shares of wind turbine maker Suzlon Energy today surged nearly 20 per cent, adding Rs 1,089 crore to its market value, following definitive pacts with Dilip Shanghvi Family and Associates (DSA) for equity investments of Rs 1,800 crore.

Shanghvi, associates make open offer for 26% stake in Suzlon

Last Updated: Monday, February 16, 2015, 17:41

Within days of committing to invest in wind turbine maker Suzlon, Dilip Shanghvi Family and Associates have made an open offer to buy another 26 percent stake for Rs 2,837 crore in the company.

Dilip Shanghvi's mother gifts Sun Pharma shares to his wife

Last Updated: Tuesday, February 3, 2015, 21:36

Sun Pharma Managing Director Dilip Shanghvi's mother Kumud S Shanghvi, one of the promoters of Sun Pharma, has gifted nearly 31 lakh shares worth Rs 282 crore to her daughter-in-law Vibha D Shanghvi.

Sun Pharma Q2 net declines 47% to Rs 320 crore

Last Updated: Thursday, November 8, 2012, 18:23

The company had posted a net profit of Rs 597.74 crore during the corresponding period of previous fiscal, Sun Pharma said in a statement.

Telenor signs Lakshdeep as its new partner

Last Updated: Friday, October 26, 2012, 18:48

After ending its telecom joint venture Uninor with Unitech, Norway's Telenor on Friday said it has signed Lakshdeep Investments and Finance as the partner for its newly formed Indian entity Telewings Communications.

Sun Pharma to partner Telenor for India JV: Report

Last Updated: Friday, October 26, 2012, 12:26

After parting ways with Unitech, Telenor has finally found a new partner for its telecom operations in India.

Sun Pharma Q4 net at Rs 820 cr; Shanghvi steps down as Chairman

Last Updated: Tuesday, May 29, 2012, 18:55

The company had posted a net profit of Rs 442.75 crore for the same period of previous fiscal, Sun Pharma said in a filing to the BSE.

Sun Pharma's Dilip Shanghvi buys 3.5% stake in Natco Pharma

Last Updated: Thursday, December 8, 2011, 19:47

Sun Pharma's chief Dilip S Shanghvi has bought 10 lakh shares or about 3.5 percent stake in the drugmaker's smaller rival Natco Pharma for an estimated Rs 25 crore.

Sun Pharma net up 19% at Rs 598 cr

Last Updated: Sunday, November 13, 2011, 17:55

Drug maker Sun Pharmaceutical Industries on Saturday reported 19 percent growth in net profit to Rs 598 crore for the quarter ended September 30, on account of robust performance across its businesses.